<DOC>
	<DOC>NCT00326586</DOC>
	<brief_summary>This is a Phase I Dose-Escalation Study of BMS641988 in Patients with Castration-Resistant Prostate Cancer.</brief_summary>
	<brief_title>A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Advanced castrationresistant prostate carcinoma with progressive disease At least 4 weeks must have elapsed from major surgery Patient must be available for followup Adequate liver and kidney function Adequate blood values Uncontrolled or significant heart disease History of seizures History of head injury, loss of consciousness, or stroke Patients undergoing alcohol withdrawal Any concurrent cancer A serious uncontrolled medical disorder or active infection Inability to swallow tablets</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>